0,976  0,001  Cardiovascular analeptic
0,834  0,004  CYP2C19 substrate
0,816  0,005  Respiratory analeptic
0,814  0,004  NOS2 expression inhibitor
0,811  0,015  Apoptosis agonist
0,788  0,013  Caspase 9 stimulant
0,781  0,007  Radioprotector
0,778  0,010  Antineoplastic (lung cancer)
0,767  0,012  Antineoplastic (breast cancer)
0,748  0,004  Skin whitener
0,722  0,008  Aryl hydrocarbon receptor agonist
0,725  0,011  CYP2C9 substrate
0,730  0,017  Transcription factor NF kappa B inhibitor
0,716  0,003  Melanin inhibitor
0,715  0,007  CYP2D6 substrate
0,714  0,006  UGT1A9 substrate
0,728  0,026  Antiinflammatory
0,695  0,008  Analeptic
0,681  0,006  Antioxidant
0,679  0,006  Caspase 3 stimulant
0,662  0,005  CYP1A2 inhibitor
0,659  0,007  AR expression inhibitor
0,651  0,007  Lipoxygenase inhibitor
0,636  0,007  Free radical scavenger
0,637  0,019  15-Lipoxygenase inhibitor
0,626  0,012  Chemopreventive
0,629  0,021  TNF expression inhibitor
0,645  0,044  Alpha-glucosidase inhibitor
0,609  0,008  UGT1A6 substrate
0,588  0,005  Monophenol monooxygenase inhibitor
0,597  0,025  Antileukemic
0,581  0,010  Ulceration
0,574  0,011  CYP2C19 inhibitor
0,563  0,012  Nitric oxide antagonist
0,576  0,026  Antineoplastic (colorectal cancer)
0,555  0,005  UGT1A3 substrate
0,562  0,014  Antiosteoporotic
0,570  0,025  Antineoplastic (colon cancer)
0,550  0,009  Antimutagenic
0,557  0,017  Spasmolytic
0,551  0,017  Antineoplastic (cervical cancer)
0,551  0,019  Bone diseases treatment
0,548  0,016  Cytostatic
0,546  0,014  Antineoplastic (brain cancer)
0,541  0,011  Hypoxia-inducible factor 1 alpha inhibitor
0,540  0,014  Antineoplastic (glioma)
0,538  0,018  Histamine release inhibitor
0,540  0,022  Antihypercholesterolemic
0,535  0,026  Prostate cancer treatment
0,530  0,023  Antineoplastic (ovarian cancer)
0,515  0,009  UGT1A1 substrate
0,522  0,019  Antineoplastic (pancreatic cancer)
0,512  0,009  UGT2B4 substrate
0,513  0,010  Antineoplastic enhancer
0,512  0,011  Vasodilator
0,526  0,026  Immunosuppressant
0,508  0,015  Antiparasitic
0,512  0,022  CYP1A2 substrate
0,491  0,005  VCAM1 expression inhibitor
0,500  0,018  Antineoplastic (multiple myeloma)
0,489  0,007  MAO inhibitor
0,490  0,014  ICAM1 expression inhibitor
0,511  0,037  Antibacterial
0,491  0,023  Sensitization
0,486  0,020  Proliferative diseases treatment
0,484  0,026  Antineoplastic (melanoma)
0,468  0,012  Antihelmintic
0,460  0,006  5 Hydroxytryptamine uptake stimulant
0,468  0,020  Antiprotozoal (Leishmania)
0,446  0,007  Lipid peroxidase inhibitor
0,451  0,016  Antihypertriglyceridemic
0,444  0,016  Antineoplastic (renal cancer)
0,455  0,031  Antifungal
0,466  0,045  5 Hydroxytryptamine release inhibitor
0,446  0,029  Lipoprotein disorders treatment
0,421  0,008  MAO A inhibitor
0,417  0,008  Protein-tyrosine phosphatase inhibitor
0,431  0,023  Hypoglycemic
0,410  0,011  Antihypotensive
0,427  0,032  Apoptosis antagonist
0,402  0,008  NOS3 expression enhancer
0,404  0,011  Platelet adhesion inhibitor
0,397  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,442  0,052  CYP3A4 substrate
0,412  0,025  Superoxide dismutase inhibitor
0,408  0,033  Chemoprotective
0,387  0,012  Antineoplastic (squamous cell carcinoma)
0,378  0,004  Carbonic anhydrase XIII inhibitor
0,394  0,021  UDP-glucuronosyltransferase substrate
0,444  0,071  Alzheimer's disease treatment
0,380  0,008  Acetylcholinesterase inhibitor
0,393  0,026  Amyloid beta aggregation inhibitor
0,388  0,022  Antiulcerative
0,382  0,015  Hepatoprotectant
0,380  0,013  UGT2B7 substrate
0,395  0,029  Antiamyloidogenic
0,372  0,009  MAO B inhibitor
0,392  0,029  Antineoplastic (glioblastoma multiforme)
0,379  0,018  P-glycoprotein inhibitor
0,395  0,037  Vasodilator, coronary
0,366  0,012  Amylase inhibitor
0,401  0,057  CYP2C9 inhibitor
0,347  0,007  5-Lipoxygenase inhibitor
0,343  0,008  Alkaline phosphatase inhibitor
0,365  0,030  Antineoplastic (liver cancer)
0,369  0,035  Carcinogenic
0,345  0,012  UGT2B15 substrate
0,367  0,035  Antipyretic
0,361  0,030  Vascular (periferal) disease treatment
0,330  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,358  0,033  Myocardial infarction treatment
0,323  0,004  Gastritis treatment
0,342  0,026  GST M1-1 substrate
0,320  0,005  Phosphodiesterase 4D inhibitor
0,326  0,012  Neurotrophic factor enhancer
0,317  0,005  Beta glucuronidase inhibitor
0,354  0,049  CYP3A4 inhibitor
0,310  0,009  UGT2B9 substrate
0,315  0,019  Carcinogenic, group 3
0,350  0,054  NOS3 expression inhibitor
0,335  0,039  Hypolipemic
0,339  0,046  Antineoplastic (non-small cell lung cancer)
0,297  0,004  Photosensitizer
0,302  0,010  Carcinogenic, group 1
0,317  0,025  Non-steroidal antiinflammatory agent
0,304  0,016  Protein kinase stimulant
0,333  0,046  DNA damaging
0,329  0,047  Antiprotozoal (Trypanosoma)
0,290  0,011  Butyrylcholinesterase inhibitor
0,361  0,082  GST A substrate
0,295  0,019  Cholinergic
0,300  0,030  UGT1A4 substrate
0,283  0,013  Cholesterol synthesis inhibitor
0,292  0,023  Antineoplastic (carcinoma)
0,316  0,049  Cytotoxic
0,318  0,052  Antihypoxic
0,264  0,002  Exportin-1 inhibitor
0,330  0,068  Streptokinase A inhibitor
0,279  0,017  Phospholipase A2 inhibitor
0,270  0,009  Antibacterial (Helicobacter pylori)
0,294  0,036  Tyrosine 3 hydroxylase inhibitor
0,280  0,024  CYP2B6 inhibitor
0,322  0,068  12-Lipoxygenase inhibitor
0,256  0,009  Breast cancer-resistant protein inhibitor
0,310  0,066  CTGF expression inhibitor
0,312  0,071  Antimycobacterial
0,259  0,019  Cyclooxygenase 1 inhibitor
0,314  0,080  Antithrombotic
0,246  0,014  Phobic disorders treatment
0,308  0,078  Hepatic disorders treatment
0,231  0,006  Electron transport complex I inhibitor
0,232  0,007  Aromatase inhibitor
0,255  0,032  Insulin sensitizer
0,260  0,042  DNA methyltransferase I inhibitor
0,344  0,127  Cyclophilin D inhibitor
0,344  0,127  Antidiabetic
0,260  0,044  RNA-directed DNA polymerase inhibitor
0,271  0,059  Antineoplastic (lymphoma)
0,216  0,005  Lipase inhibitor
0,219  0,011  Coagulant
0,224  0,016  Antihemorrhagic
0,222  0,015  Interleukin 1b antagonist
0,235  0,028  LDLR expression enhancer
0,230  0,029  Bone formation stimulant
0,224  0,023  UGT2B10 substrate
0,280  0,087  Antineoplastic (osteosarcoma)
0,210  0,017  Carbonic anhydrase XV inhibitor
0,212  0,022  Arachidonic acid antagonist
0,207  0,018  Xanthine oxidase inhibitor
0,219  0,035  Cyclooxygenase inhibitor
0,188  0,004  Ca(v)3.1 blocker
0,185  0,004  Potassium channel Kv1.3 blocker
0,193  0,012  TRPA1 agonist
0,211  0,031  Antidiarrheal
0,263  0,083  5 Hydroxytryptamine release stimulant
0,235  0,058  Mutagenic
0,300  0,124  Antiprotozoal
0,183  0,010  CYP2A6 inhibitor
0,263  0,090  Cardioprotectant
0,227  0,054  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,203  0,031  Antifungal enhancer
0,183  0,011  ABCA1 expression enhancer
0,277  0,106  Cholesterol antagonist
0,230  0,060  DNA methylase inhibitor
0,176  0,006  Ornithine decarboxylase inhibitor
0,246  0,077  Teratogen
0,203  0,034  Genotoxic
0,190  0,022  Microtubule formation inhibitor
0,203  0,036  Tubulin antagonist
0,272  0,107  FMO1 substrate
0,202  0,037  Heat shock protein 90 antagonist
0,213  0,049  Dual specificity phosphatase inhibitor
0,209  0,047  3C-like protease (Human coronavirus) inhibitor
0,177  0,017  Dementia treatment
0,221  0,062  Wound healing agent
0,166  0,010  Peroxisome proliferator-activated receptor gamma agonist
0,160  0,005  Neuraminidase inhibitor
0,232  0,078  Antineoplastic (lymphocytic leukemia)
0,167  0,013  Inducible nitric-oxide synthase inhibitor
0,171  0,017  Vascular dementia treatment
0,235  0,082  Tumour necrosis factor alpha release inhibitor
0,243  0,092  Radiosensitizer
0,262  0,114  Angiogenesis inhibitor
0,185  0,040  Interleukin 1 antagonist
0,168  0,025  Choleretic
0,278  0,137  Antipruritic, allergic
0,189  0,049  Antiviral (Influenza A)
0,198  0,059  VEGF expression inhibitor
0,234  0,097  Transcription factor STAT3 inhibitor
0,168  0,034  Cyclooxygenase 3 inhibitor
0,169  0,036  Farnesoid X receptor antagonist
0,158  0,025  Mediator release inhibitor
0,201  0,071  Abortion inducer
0,215  0,085  Embryotoxic
0,151  0,021  Carcinogenic, group 2A
0,175  0,047  GABA C receptor rho-2 antagonist
0,161  0,033  Beta amyloid protein antagonist
0,141  0,014  CDC25A inhibitor
0,171  0,045  Antiseptic
0,154  0,027  Carbonic anhydrase III inhibitor
0,231  0,104  Immunostimulant
0,160  0,037  Cystathionine beta-synthase inhibitor
0,152  0,030  Antineoplastic antibiotic
0,132  0,010  Neuraminidase (influenza) inhibitor
0,187  0,066  Male reproductive disfunction treatment
0,164  0,045  Cyclooxygenase 2 inhibitor
0,177  0,058  Antiviral (Herpes)
0,142  0,025  Phosphodiesterase IV inhibitor
0,139  0,022  NAD(P)H dehydrogenase (quinone) inhibitor
0,159  0,044  DNA polymerase I inhibitor
0,176  0,063  ATPase inhibitor
0,258  0,147  GABA C receptor rho-3 antagonist
0,114  0,004  Transcription factor RelA inhibitor
0,129  0,020  Antifungal (Aspergillus)
0,149  0,040  Vanilloid 1 agonist
0,144  0,036  Mucolytic
0,134  0,026  Antiviral (SARS coronavirus)
0,134  0,026  Antiviral (Coronavirus)
0,205  0,097  Platelet antagonist
0,133  0,025  Carbonic anhydrase VI inhibitor
0,133  0,029  Calcium antagonist
0,121  0,019  ATPase (Vacuolar H+) inhibitor
0,148  0,047  Ca2+-transporting ATPase inhibitor
0,106  0,005  Retinoid X alpha receptor agonist
0,215  0,115  Antituberculosic
0,135  0,037  Antifungal (Pneumocystis)
0,155  0,059  Antiacne
0,115  0,019  Na+ K+ transporting ATPase inhibitor
0,182  0,086  Antiviral (Influenza)
0,123  0,028  Estrogen receptor beta antagonist
0,100  0,005  Peroxisome proliferator-activated receptor delta antagonist
0,117  0,023  Bile acid receptor antagonist
0,131  0,038  Sulfotransferase substrate
0,184  0,091  Pneumotoxic
0,121  0,030  Thioredoxin inhibitor
0,207  0,116  Antineoplastic (sarcoma)
0,130  0,039  Estrogen antagonist
0,111  0,020  Leukotriene synthesis inhibitor
0,140  0,050  Antiprotozoal (Amoeba)
0,170  0,080  Succinate dehydrogenase inhibitor
0,104  0,017  Postmenopausal disorders treatment
0,195  0,107  Aldehyde oxidase inhibitor
0,149  0,063  CNS active muscle relaxant
0,140  0,054  Topoisomerase II inhibitor
0,103  0,018  Phosphodiesterase VI inhibitor
0,121  0,037  Nitric-oxide synthase inhibitor
0,156  0,072  Diuretic
0,129  0,045  Expectorant
0,119  0,035  UGT2B11 substrate
0,188  0,105  Antiglaucomic
0,224  0,142  Prostaglandin dehydrogenase inhibitor
0,190  0,108  Nitric-oxide synthase stimulant
0,096  0,016  Androgen agonist
0,154  0,075  Eye irritation, high
0,083  0,007  Retinoid X receptor agonist
0,166  0,092  Antirickettsial
0,129  0,056  Contraceptive female
0,158  0,085  Muscle relaxant
0,084  0,011  Postcoital contraceptive
0,079  0,007  Pregnane X receptor antagonist
0,111  0,039  Androgen antagonist
0,075  0,005  DNA gyrase subunit A inhibitor
0,102  0,032  Granulocyte macrophage colony stimulating factor agonist
0,173  0,104  Cardiodepressant
0,135  0,067  Death-associated protein kinase 1 inhibitor
0,278  0,210  Antineoplastic (solid tumors)
0,090  0,023  Peroxisome proliferator-activated receptor gamma antagonist
0,148  0,081  Interferon gamma antagonist
0,083  0,016  Peroxisome proliferator-activated receptor alpha agonist
0,100  0,036  Chymotrypsin inhibitor
0,096  0,033  Keratolytic
0,115  0,053  UGT2B1 substrate
0,200  0,139  Transcription factor STAT inhibitor
0,120  0,059  Skin irritative effect
0,198  0,138  Antidiabetic (type 2)
0,155  0,097  Antineoplastic (gastric cancer)
0,115  0,057  Glutathione S-transferase substrate
0,071  0,015  Glucose-6-phosphate translocase inhibitor
0,065  0,009  Inosine monophosphate dehydrogenase inhibitor
0,061  0,005  Retinoid X receptor antagonist
0,112  0,059  Carcinogenic, group 2B
0,214  0,161  Vasodilator, peripheral
0,220  0,171  Antiprotozoal (Plasmodium)
0,111  0,063  Chelator
0,192  0,145  Antineoplastic (bladder cancer)
0,086  0,040  Estrogen receptor alpha antagonist
0,052  0,005  Retinoid X alpha receptor antagonist
0,081  0,037  Prokinetic
0,060  0,017  Liver X receptor agonist
0,066  0,022  Acetyl-CoA transferase 2 inhibitor
0,155  0,112  Psychostimulant
0,176  0,134  Antidiabetic symptomatic
0,132  0,092  Antifungal (Cryptococcus)
0,048  0,008  Leukotriene B4 receptor 1 antagonist
0,053  0,014  Squalene synthetase inhibitor
0,077  0,039  Carbonic anhydrase VA inhibitor
0,097  0,059  Interleukin 12 antagonist
0,083  0,044  Antibiotic
0,086  0,049  Topoisomerase II alpha inhibitor
0,235  0,198  Transcription factor inhibitor
0,046  0,009  Peroxisome proliferator-activated receptor alpha antagonist
0,062  0,026  Leukotriene B4 antagonist
0,057  0,021  Carbonic anhydrase VII inhibitor
0,069  0,033  Antimycoplasmal
0,194  0,158  Gastrin inhibitor
0,153  0,118  Antimitotic
0,080  0,046  GABA aminotransferase inhibitor
0,103  0,068  GST T1-1 substrate
0,074  0,040  Carbonic anhydrase V inhibitor
0,051  0,018  5-Alpha-reductase inhibitor
0,219  0,186  Calcium channel activator
0,224  0,193  Atherosclerosis treatment
0,037  0,006  Leukotriene B4 receptor 2 antagonist
0,057  0,026  Vanilloid 2 antagonist
0,122  0,092  Antiparkinsonian, tremor relieving
0,087  0,056  Transcription factor NF kappa B stimulant
0,149  0,119  Sepsis treatment
0,054  0,025  Factor III inhibitor
0,099  0,070  Gout treatment
0,094  0,067  Sphingomyelinase inhibitor
0,052  0,025  Cytokine production stimulant
0,136  0,110  Dual specificity phosphatase 3 inhibitor
0,060  0,035  Carbonic anhydrase VB inhibitor
0,066  0,042  CDC25B inhibitor
0,090  0,066  Antiviral (Rhinovirus)
0,031  0,008  Inosine monophosphate dehydrogenase 2 inhibitor
0,182  0,159  Antiviral (West Nile virus)
0,066  0,044  Leukotriene antagonist
0,091  0,070  Interleukin 1 beta converting enzyme inhibitor
0,039  0,018  Peroxisome proliferator-activated receptor delta agonist
0,058  0,037  Fatty acid synthase inhibitor
0,042  0,021  Progesterone antagonist
0,029  0,009  Inosine monophosphate dehydrogenase 1 inhibitor
0,054  0,033  Estrogen agonist
0,029  0,009  5-Alpha-reductase 1 inhibitor
0,049  0,030  Aldosterone antagonist
0,051  0,032  Bombesin 2 receptor antagonist
0,041  0,024  Retinoic acid alpha receptor agonist
0,080  0,062  Caspase 7 inhibitor
0,117  0,099  Acaricide
0,095  0,078  Antiprotozoal (Toxoplasma)
0,048  0,032  Glucose-6-phosphate isomerase inhibitor
0,183  0,168  CYP2D6 inhibitor
0,121  0,106  Antiprotozoal (Coccidial)
0,049  0,034  Carbonic anhydrase XIV inhibitor
0,184  0,169  Thyroid hormone beta antagonist
0,070  0,055  Glycine receptor agonist
0,138  0,124  Diabetic nephropathy treatment
0,116  0,104  Peroxidase inhibitor
0,050  0,039  Aldose reductase inhibitor
0,057  0,046  Ryanodine receptor antagonist
0,132  0,122  Sedative
0,022  0,013  Neuraminidase (Influenza B) inhibitor
0,089  0,080  GABA C receptor rho-1 antagonist
0,047  0,039  Squalene epoxidase inhibitor
0,057  0,050  Transcription factor AP-1 inhibitor
0,179  0,172  Antipsoriatic
0,160  0,154  ErbB-1 antagonist
0,113  0,108  Neurotrophic factor
0,097  0,094  Acetylcholine release stimulant
0,030  0,027  Melatonin 2 agonist
0,076  0,074  Thioredoxin reductase inhibitor
0,181  0,178  Thyroid hormone antagonist
0,109  0,107  Antiprotozoal (Trichomonas)
0,051  0,049  Dihydroorotate oxidase inhibitor
0,059  0,058  Phosphofructokinase-1 inhibitor
0,076  0,075  GST P1-1 substrate
0,133  0,133  Anesthetic general

